The latest news:

• FDA Grants Orphan Drug Designation for Tocagen's Toca 511 & Toca FC, an Investigational Immuno-Oncology Treatment for Glioblastoma         Great news for brain tumor patients!
  



• Enrollment Begins In Expansion Phase of ONC201 Clinical Trial         This study will allow brain tumor patients to participate.  We funded some of the preclinical work on this. Great to see it move into human trials!
  



• Treating Brain Tumor with Microbeam Radiation Generated by a Compact Carbon-Nanotube-Based Irradiator: Initial Radiation Efficacy Study.         We funded some of the earlier studies mentioned. This is a big step toward human trials.
  



• Computed modeling of alternating electric fields therapy for recurrent glioblastoma.         It is always great to find out why a treatment fails, and how to make it work better. Novocure now has a system in place where the doctor can shape the field by determining placement of the electrodes to better hit the tumor compared to the first generation of the system
  



• WEBINAR ALERT: Consensus Recommendations for a Standardized Brain Tumor Imaging Protocol (BTIP) in Clinical Trials         This webinar is for the people who are involved in designing brain tumor clinical trials.   It is a project we are working on to speed up the search for the cure.  Standardizing the brain tumor scans across all MRI machines will allow for more accuracy when comparing scans, speeding up the process and reducing costs.
  

BrainTumor Co-Payment Assistance Program Status:

• CLOSED to new applicants